Evidence map›Paper›PMID 35281100›Full record

ArticleFrontiers in cell and developmental biology2022

Radiomics of Contrast-Enhanced Computed Tomography: A Potential Biomarker for Pretreatment Prediction of the Response to

Lei Ye, Yuntian Chen, Hui Xu, Zhaoxiang Wang, Haixia Li, Jin Qi, Jing Wang, Jin Yao, Jiaming Liu, Bin Song

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. The Stalk Sign in Bladder Cancer: CEUS Versus MRI.Diagnostics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Lei YeDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Yuntian ChenDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Hui XuDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Zhaoxiang WangDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Haixia LiPhilips Healthcare, Chengdu, China.
Jin QiUniversity of Electronic Science and Technology of China, Chengdu, China.
Jing WangUniversity of Electronic Science and Technology of China, Chengdu, China.
Jin YaoDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Jiaming LiuDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Bin SongDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
West China Hospital of Sichuan University · CNSichuan University · CNUniversity of Electronic Science and Technology of China · CNPhilips (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BCG immunotherapyCECT imagesNMF (nonnegative matrix factorization)NMIBC (non-muscle-invasive bladder cancer)radiomics analysis

Identifiers

PMID35281100
PMCPMC8914064
OpenAlexW4214663542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.